Acutus Medical Inc
OTC:AFIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arshiya Ltd
NSE:ARSHIYA
|
IN |
|
China Investment Fund Co Ltd
HKEX:612
|
HK |
|
X
|
xReality Group Ltd
ASX:XRG
|
AU |
|
T
|
Tempus Holdings Ltd
HKEX:6880
|
HK |
|
Tirupati Sarjan Ltd
BSE:531814
|
IN |
|
JFE Systems Inc
TSE:4832
|
JP |
|
M
|
M-Grass Ecology and Environment Group Co Ltd
SZSE:300355
|
CN |
|
Capallianz Holdings Ltd
SGX:594
|
SG |
|
Netmedia Group
PAR:ALNMG
|
FR |
|
Accordant Group Ltd
NZX:AGL
|
NZ |
Acutus Medical Inc
EPS (Diluted)
Acutus Medical Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Acutus Medical Inc
OTC:AFIB
|
EPS (Diluted)
$0
|
CAGR 3-Years
57%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Acutus Medical Inc
Glance View
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 338 full-time employees. The company went IPO on 2020-08-06. The firm designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The Company’s lead product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly and accurately identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms.
See Also
What is Acutus Medical Inc's EPS (Diluted)?
EPS (Diluted)
-0.3
USD
Based on the financial report for Dec 31, 2024, Acutus Medical Inc's EPS (Diluted) amounts to -0.3 USD.
What is Acutus Medical Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
39%
Over the last year, the EPS (Diluted) growth was 89%. The average annual EPS (Diluted) growth rates for Acutus Medical Inc have been 57% over the past three years , 39% over the past five years .
